Brad Gerstner Portfolio: Top 7 New Stock Picks
Strategists and investors are confident that the new administration will fuel the state of mergers and acquisitions in the United States.
Lineage Cell Therapeutics Inc. (LCTX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Broadwood Capital Neal C. Bradsher | 41,666,255 | $20,937,293 | 1.63% | |
| 2. | Perceptive Advisors Joseph Edelman | 7,236,843 | $3,636,514 | 0.1% | |
| 3. | Alyeska Investment Group Anand Parekh | 3,947,369 | $1,983,553 | 0% | |
| 4. | DAFNA Capital Management Nathan Fischel | 2,511,374 | $1,261,965 | +86% | 0.32% |
| 5. | Renaissance Technologies Jim Simons | 2,283,072 | $1,147,244 | +1059% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 0 | Large Shareholder, Director | 49,560,992 | 2025-01-27 | Filing | |
| $0.76 | 7,894,737 | Large Shareholder, Director | 49,560,992 | 2025-01-27 | Filing | |
| $0.59 | 15,000 | 25,500 | 2024-11-26 | Filing | ||
| $0.60 | 15,000 | 22,184 | 2024-11-26 | Filing | ||
| $0.57 | 40,000 | 298,555 | 2024-11-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.44 | 28,445 | Officer | 0 | 2021-12-29 | Filing | |
| $2.49 | 9,250 | Officer | 28,445 | 2021-12-29 | Filing | |
| $2.45 | 501,588 | Officer | 28,445 | 2021-12-28 | Filing | |
| $2.93 | 19,142 | Director | 15,578 | 2021-06-29 | Filing | |
| $2.97 | 4,720 | Director | 87,500 | 2021-06-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,094,677 | $5,072,576 | 0% | |
| 2. | 8,632,928 | $4,342,363 | 0% | |
| 3. | 5,963,348 | $2,996,582 | 1.1% | |
| 4. | 5,492,088 | $2,759,774 | 2.97% | |
| 5. | 3,690,486 | $1,854,859 | 0% |
News See All
Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks
In this article, we will take a detailed look at Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks.
Top 10 Growth Stocks in Biotech
The biotech industry encompasses a wide range of fields, including genetic engineering, biomanufacturing, bioinformatics, and synthetic biology.
5 Best Biotech Penny Stocks To Buy Now
In this article, we will be taking a look at the 5 best biotech penny stocks to buy now.
10 Best One Dollar Stocks To Buy Now
In this article, we discuss the 10 best one dollar stocks to buy now.
10 Best Penny Stocks to Buy in July
Penny stocks are priced under $5 and often represent high-risk public companies that do offer exponential growth potential.
5 Biotech Penny Stocks to Buy According to Reddit
In this article, we discuss the 5 biotech penny stocks to buy according to Reddit.
Is Lineage Cell Therapeutics (LCTX) A Good Stock To Buy Now?
A whopping number of 13F filings filed with U.S.
Hedge Funds Are Nibbling On Lineage Cell Therapeutics, Inc. (LCTX)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Should You Buy Lineage Cell Therapeutics, Inc. (LCTX)?
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end of June.
Billionaire Hedge Funds
